ReP USP - Resultado da busca

Filtros : "EERP" "Nova Zelândia" Removidos: "Revista Brasileira de Enfermagem" "REDE-TB" Limpar

Filtros

Autores USP
- gonella, jennifer midiani (~2)
- silveira, carolina galli da (~1)
- sousa, fernanda raphael escobar gimenes de (~1)
Ano de publicação
- 2021 (~1)
- 2020 (~1)
Assuntos
- cardiologia (1)
- dor crônica (1)
- estudos retrospectivos (1)
- fármacos (sistema cardiovascular) (1)
- fármacos psicotrópicos (1)

Colaboração institucional
Afiliação dos autores externos normalizada
Afiliação dos autores externos não normalizada
- bureau d’information et d’études en santé des populations, institut national de santé publique du québec, quebec city, qc (1)
- centre de recherche de l’institut universitaire de cardiologie et de pneumologie de québec-université laval, quebec city (1)
- centre de recherche du centre hospitalier universitaire ste-justine, montreal (1)
- department of nursing, faculty of health sciences, university of pécs, pécs (1)
- department of nursing, université du québec à trois-rivières, trois-rivières, qc (1)

Artigo de periodico
Reporting rates of opioid‑related adverse events since 1965 in Canada: a descriptive retrospective study (2021)
Lavallée, Maude; Silveira, Carolina Galli da ; Akinola, Samuel; Méthot, Julie; Piché, Marie‑Eve; Bérard, Anick; Thibault, Magalie; Gonella, Jennifer Midiani; Gimenes, Fernanda Raphael Escobar ; Leclerc, Jacinthe
Fonte: Drugs - Real World Outcomes. Unidade: EERP
Assuntos: ÓPIO, FÁRMACOS PSICOTRÓPICOS, DOR CRÔNICA, PACIENTES AMBULATORIAIS, ESTUDOS RETROSPECTIVOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
LAVALLÉE, Maude et al. Reporting rates of opioid‑related adverse events since 1965 in Canada: a descriptive retrospective study. Drugs - Real World Outcomes, p. 1-12, 2021Tradução . . Disponível em: https://doi.org/10.1007/s40801-021-00275-2. Acesso em: 21 maio 2024.
APA
Lavallée, M., Silveira, C. G. da, Akinola, S., Méthot, J., Piché, M. ‑E., Bérard, A., et al. (2021). Reporting rates of opioid‑related adverse events since 1965 in Canada: a descriptive retrospective study. Drugs - Real World Outcomes, 1-12. doi:10.1007/s40801-021-00275-2
NLM
Lavallée M, Silveira CG da, Akinola S, Méthot J, Piché M‑E, Bérard A, Thibault M, Gonella JM, Gimenes FRE, Leclerc J. Reporting rates of opioid‑related adverse events since 1965 in Canada: a descriptive retrospective study [Internet]. Drugs - Real World Outcomes. 2021 ; 1-12.[citado 2024 maio 21 ] Available from: https://doi.org/10.1007/s40801-021-00275-2
Vancouver
Lavallée M, Silveira CG da, Akinola S, Méthot J, Piché M‑E, Bérard A, Thibault M, Gonella JM, Gimenes FRE, Leclerc J. Reporting rates of opioid‑related adverse events since 1965 in Canada: a descriptive retrospective study [Internet]. Drugs - Real World Outcomes. 2021 ; 1-12.[citado 2024 maio 21 ] Available from: https://doi.org/10.1007/s40801-021-00275-2
Artigo de periodico
Are generic drugs used in cardiology as effective and safe as their brand-name counterparts? A systematic review and meta-analysis (2020)
Leclerc, Jacinthe; Thibault, Magalie; Midiani Gonella, Jennifer; Beaudoin, Claudia; Sampalis, John
Fonte: Drugs. Unidade: EERP
Assuntos: MEDICAMENTO GENÉRICO, CARDIOLOGIA, FÁRMACOS (SISTEMA CARDIOVASCULAR), REVISÃO SISTEMÁTICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
LECLERC, Jacinthe et al. Are generic drugs used in cardiology as effective and safe as their brand-name counterparts? A systematic review and meta-analysis. Drugs, v. 80, n. 7, p. 697-710, 2020Tradução . . Disponível em: https://doi.org/10.1007/s40265-020-01296-x. Acesso em: 21 maio 2024.
APA
Leclerc, J., Thibault, M., Midiani Gonella, J., Beaudoin, C., & Sampalis, J. (2020). Are generic drugs used in cardiology as effective and safe as their brand-name counterparts? A systematic review and meta-analysis. Drugs, 80( 7), 697-710. doi:10.1007/s40265-020-01296-x
NLM
Leclerc J, Thibault M, Midiani Gonella J, Beaudoin C, Sampalis J. Are generic drugs used in cardiology as effective and safe as their brand-name counterparts? A systematic review and meta-analysis [Internet]. Drugs. 2020 ; 80( 7): 697-710.[citado 2024 maio 21 ] Available from: https://doi.org/10.1007/s40265-020-01296-x
Vancouver
Leclerc J, Thibault M, Midiani Gonella J, Beaudoin C, Sampalis J. Are generic drugs used in cardiology as effective and safe as their brand-name counterparts? A systematic review and meta-analysis [Internet]. Drugs. 2020 ; 80( 7): 697-710.[citado 2024 maio 21 ] Available from: https://doi.org/10.1007/s40265-020-01296-x

Biblioteca Digital de Produção Intelectual da Universidade de São Paulo 2012 - 2024